The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in real time based on the patient’s brain activity, according to the ...
The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...
16h
Hosted on MSNFDA OKs adaptive brain pacemaker for Parkinson's treatmentThe Food and Drug Administration on Monday granted its first approval for a pacemaker-like device for the brain to ease ...
A UC San Diego-led team's project to develop next-generation brain implants builds on the development of this transparent ...
Some FDA scientists said they were not sure if they wanted to return. The U.S. Food and Drug Administration is asking some of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results